Congress planning today: Pain points and opportunities
Between December 2023 and February 2024, we conducted a two-phase multi-methodology research study, collecting feedback from global pharmaceutical company employees whose job roles involve the planning and delivery of congress.
In this report, we uncover the challenges faced by congress planners working in pharma, what is required to mitigate these challenges, and ultimately, how you can improve the execution of future congress events. We explore key research and findings, such as:
- ‘Congress is still a high-value activity for pharma’
- ‘Value is being lost in the complexities of delivery’
- ‘Smarter ROI measurements reveal known unknowns’
- ‘Overcoming complexities in congress execution’
Download the report.
Jump to a slide with the slide dots.
AI in clinical trials: How AI is optimizing trial design, safety, and drug development
Discover how AI can significantly accelerate drug development by enhancing various aspects of clinical trial design in this article.
Read moreDeconstructing Workflows: Breaking tradition to breakthrough new therapies
The pharmaceutical industry is undergoing a significant transformation driven by numerous factors. These include the...
Read more2025 data, tech, and AI trends: What you need to know.
In this report, Inizio experts provide key updates on how human partnership with AI has been used to create value at pivotal moments, driving commerci
Read more